Evidence map›Paper›PMID 38739802›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Dichotomous transactivation domains contribute to growth inhibitory and promotion functions of TAp73.

Dan Li, Catherine Yen Li Kok, Chao Wang, Debleena Ray, Susanne Osterburg, Volker Dötsch, Sujoy Ghosh, Kanaga Sabapathy

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Dichotomous transactivation domains contribute to growth inhibitory and promotion functions of TAp73.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dan LiDivision of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 168583, Singapore.ORCID 0000-0001-8481-9598
Catherine Yen Li KokDivision of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 168583, Singapore.
Chao WangDivision of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 168583, Singapore.
Debleena RayProgramme in Cancer and Stem Cell Biology, Duke-National University of Singapore (NUS) Medical School, Singapore 169857, Singapore.
Susanne OsterburgInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main 60438, Germany.
Volker DötschInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University, Frankfurt am Main 60438, Germany.
Sujoy GhoshCentre for Computational Biology & Programme in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore 169857, Singapore.
Kanaga SabapathyDivision of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 168583, Singapore.

Funding

MOH | National Medical Research Council (NMRC) Centre grantNational Research Foundation Singapore (NRF) NRF-NRFI2015-07SingHealth Foundation SHF/FG693S/2016
6 · The paper itself

Abstract

The transcription factor p73, a member of the p53 tumor-suppressor family, regulates cell death and also supports tumorigenesis, although the mechanistic basis for the dichotomous functions is poorly understood. We report here the identification of an alternate transactivation domain (TAD) located at the extreme carboxyl (C) terminus of TAp73β, a commonly expressed p73 isoform. Mutational disruption of this TAD significantly reduced TAp73β's transactivation activity, to a level observed when the amino (N)-TAD that is similar to p53's TAD, is mutated. Mutation of both TADs almost completely abolished TAp73β's transactivation activity. Expression profiling highlighted a unique set of targets involved in extracellular matrix-receptor interaction and focal adhesion regulated by the C-TAD, resulting in FAK phosphorylation, distinct from the N-TAD targets that are common to p53 and are involved in growth inhibition. Interestingly, the C-TAD targets are also regulated by the oncogenic, amino-terminal-deficient DNp73β isoform. Consistently, mutation of C-TAD reduces cellular migration and proliferation. Mechanistically, selective binding of TAp73β to DNAJA1 is required for the transactivation of C-TAD target genes, and silencing DNAJA1 expression abrogated all C-TAD-mediated effects. Taken together, our results provide a mechanistic basis for the dichotomous functions of TAp73 in the regulation of cellular growth through its distinct TADs.

Indexed as

Cell ProliferationProtein DomainsTranscriptional ActivationTumor Protein p73Cell Line, TumorCell MovementHumansMutationPhosphorylationProtein IsoformsTumor Suppressor Protein p53Tumor Suppressor ProteinsProtein IsoformsTP73 protein, humanTumor Protein p73Tumor Suppressor Protein p53Tumor Suppressor ProteinsapoptosisDNAJA1p53TAp73transactivation domain

Identifiers

PMID38739802
PMCPMC11127001

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.